Search results

Purpose: In patients with hemophilia B, treatment with extended half-life (EHL) recombi-nant factor IX allows for longer dosing intervals while providing equal or superior bleeding protection compared with standard half-life products. This enables flexible, individualized treatment schedules, which reduce the burden of prophylaxis and improve patient outcomes. This analysis compared the efficacy o

Rh immune globulin (WinRho SDF; Cangene, Mississauga, ON, Canada) is an effective treatment for autoimmune thrombocytopenic purpura; however, maintaining a sustained supply for its use in autoimmune thrombocytopenic purpura and its primary indication, hemolytic disease of the newborn, makes the development of alternative reagents desirable. We compared Rh immune globulin and 6 human monoclonal ant

Primary immune thrombocytopenia is an autoimmune disease associated with a reduced peripheral blood platelet count. The phenotype is variable with some patients suffering no bleeding whilst others have severe bleeding which may be fatal. Variability in clinical behaviour and treatment responses reflects its complex underlying pathophysiology. Historically the management has relied heavily on immun

The glycosylation status of IgG has been implicated in the pathology of rheumatoid arthritis. Earlier, we reported the identification of a novel secreted endo-beta-N-acetylglucosaminidase (EndoS), secreted by Streptococcus pyogenes that specifically hydrolyzes the beta-1,4-di-N-acetylchitobiose core of the asparagine-linked glycan of human IgG. Here, we analyzed the arthritogenicity of EndoS-treat

Cryogels have been demonstrated to be efficient when applied for protein isolation. Owing to their macroporous structure, cryogels can also be used for treating particle-containing material, e.g. cell homogenates. Another challenging development in protein purification technology is the use of molecularly imprinted polymers (MIPs). These MIPs are robust and can be used repeatedly. The paper presen

Kursplaner med litteraturlistor. De gäller från och med angiven termin och tills vidare. Engelsk översättning av kursplanerna finns antingen i menyn till höger eller längst ner på sidan. Ändring av kurslitteratur godkänns av ledningsgruppen för psykologprogrammet inför varje termin. Uppdaterade litteraturlistor finns därefter tillgängliga cirka 5 juni inför kommande hösttermin och cirka 5 december

https://www.psy.lu.se/utbildning/dig-som-ar-student-vara-utbildningar/psykologprogrammet/utbildningsplan-och-kursplaner-med-litteraturlistor/psp2015-och-kursplaner-1-14 - 2026-05-29

Project for Doctoral Studies in States of Consciousness (including hypnosis and dissociation) and Parapsychology Project for Doctoral Studies in States of Consciousness and Parapsychology (handledning på svenska eller engelska) As part of programmatic research on states of consciousness and anomalous psychology, my associates and I at the Center for Research on Consciousness and Anomalous Psycholo

https://www.psy.lu.se/en/sites/psy.lu.se.en/files/2017doctoralproject.pdf - 2026-05-29

Project for Doctoral Studies in States of Consciousness (including hypnosis and dissociation) and Parapsychology Project for Doctoral Studies in States of Consciousness and Parapsychology (handledning på svenska eller engelska) As part of a long-term program of research in states of consciousness and anomalous psychology, my associates and I at the Center for Research on Consciousness and Anomalou

https://www.psy.lu.se/en/sites/psy.lu.se.en/files/states_of_consciousness_and_parapsychology.doc - 2026-05-29

Årets doktorer prydda i hatt och krans Doktorspromotionen | 29 maj 2026 Examensföreställningar 2026 21 maj–3 juni Teaterhögskolans dramatiker- och skådespelartreor bjuder på fyra helt nyskrivna verk på Bryggeriteatern i Malmö.Mer om föreställningarna, speltider och biljetter Studera Har du precis gått ut gymnasiet? Har du jobbat i några år – eller kanske många år? Var du än är i livet har vi en ut

https://www.lu.se/start - 2026-05-29

https://www.nano.lu.se/sites/nano.lu.se/files/nanolund_policy_research_visits_2.pdf - 2026-05-29

Ord i mörkret Version 2 % α 33 ιœ Det œ œµ œ∀ œ œ œ bor så myc ket i D m G/D A œ œ∀ œ œ œµ or den, de är E/D A/C∀ œ œ œ œµ œ∀ œ fyll da av sa go lik D m G ˙∀ Œ ‰ ιœ kraft. Är A - - - - - % α5 œ œµ œ∀ œ œ liv li nor na på D m G/D œ œ∀ œ ‰ ιœµ jor den, de E/D A/C∀ œ œ œ œµ œ œ∀ bäs ta vi nå gon sin D m G A ˙ Œ œ haft. De D m C 7 - - -- - - - % α9 œ œ œ œ œ föl jer oss ge nom F C/F B œ œ œ œ œ œ å re

https://www.mhm.lu.se/sites/mhm.lu.se/files/2022-04/Ord%20i%20mo%CC%88rkret%20%20-%20obligatorisk%20sa%CC%8Ang%20acapella%20Sa%CC%8Ang%20GF%202022_0.pdf - 2026-05-29

https://www.khm.lu.se/en/sites/khm.lu.se.en/files/edstrandska_digital_invitation_2017.pdf - 2026-05-29

https://www.aclu.lu.se/formular/anmalan-mergers-acquisitions - 2026-05-29

This review compares the methodology of published clinical studies investigating the extended-half-life (EHL) factor VIII (FVIII) products, rFVIIIFc (efmoroctocog alfa, Elocta®/Eloctate®), BAY 94-9027 (damoctocog alfa pegol, Jivi®), BAX 855 (rurioctocog alfa pegol, Adynovate®) and N8-GP (turoctocog alfa pegol, Esperoct®) including the phase 2/3 studies, A-LONG (NCT01181128), PROTECT VIII (NCT01580

Background: A unique feature of alveolar mast cells is their low high-affinity IgE receptor (FcεRI) expression. Recent discoveries in uncontrolled asthma suggest that the appearance of FcεRI-expressing alveolar mast cells may be a novel disease-specific feature of allergic asthma. This study investigates whether increased FcεRI-expressing alveolar mast cells are present in patients with mild aller